Clinical Pharmacology Seminars are held on Tuesdays from 11:00am-noon in conference room W7120 (Wishard Myers Building (WD), 7th Floor). Campus Map
* Personalized Medicine seminar
| Date | Presenter | Title | Topic |
|---|---|---|---|
| *AUG 2 | Michael S. Sturek, Ph.D. | Professor and Chair, Department of Cellular & Integrative Physiology | Pharmacotherapy for metabolic syndrome, non-alcoholic steatohepatitis, and coronary heart disease |
| *AUG 9 | David Flockhart, MD, PhD | Director, Division of Clinical Pharmacology, IUSM IIPM Director |
Personalized Medicine in Breast Cancer |
| AUG 16 | Kartik Jinjuvadia, MD | Division of Gastroenterology/Hepatology, IU School of Medicine | Emerging role of IL-28B SNP polymorphism in the treatment of Hepatitis C - A step towards personalized medicine |
| AUG 23 | David Thacker, PharmD | Division of Clinical Pharmacology Fellow, IU School of Medicine | The Framework of the Inflammation Network in Drug Disposition |
| AUG 30 | Anne Nguyen, BSc, CCRP | Program Director, Division of Clinical Pharmacology, IU School of Medicine | Indiana Biobank |
| *SEP 6 | Samy Meroueh, PhD | Assistant Professor, Department of Biochemistry & Molecular Biology, IU School of Medicine | Proteome-Scale Molecular Docking for Drug Discovery and Repurposing in Cancer |
| SEP 7 | Lateef Aregbe, MD, BSc | Division of Clinical Pharmacology Fellow, IU School of Medicine | The effects of genetic variation on the anti-VEGF activity of PTC299 |
| SEP13 | Rob Bies, PharmD, PhD | Associate Professor, Division of Clinical Pharmacology, IU School of Medicine | Pandora for Modelers |
| SEP 20 | Nieves Velez de Mendizabal, PhD | Division of Clinical Pharmacology Fellow, IU School of Medicine | Modeling the interaction between the local and systemic analgesic effects in rats of lumiracoxib, a specific COX-2 inhibitor |
| SEP 27 | Beth Pflug, PhD | Associate Research Professor, Division of Clinical Pharmacology, IU School of Medicine | Androgen ablation, the endothelin axis & prostate cancer cell survival & progression to castration-resistant disease |
| *OCT 4 | Bruce Carleton, PharmD | Professor, Department of Pediatrics, University of British Columbia | Genetic Biomarkers of Drug Risk for Clinical Care: The Past, Present and Incredible Future |
| OCT 11 | Brian Overholser, PharmD | Associate Professor, Department of Pharmacy Practice, Purdue University | Post-translational modifications of cardiac voltage-gated potassium channels to promote arrhythmogenesis: Personalized medicine beyond transcription and translation |
| OCT 18 | Sara Quinney, PharmD, PhD | Assistant Research Professor, Department of OB/GYN | Pharmacokinetic Models of CYP3A Substrates in Pregnancy |
| WED OCT 19 1:00pm |
Stephen Fried | Investigative journalist, author of "Bitter Pills" | Bitter Pills & Antidotes: Lessons from 20 years of caregiving, and investigative reporting on pharmaceutical safety and patient advocacy |
| *OCT 25 | Malaz Boustani, MD | Associate Professor, Division of General Medicine & Geriatrics | Acute Illness and the Aging Brain |
| *NOV 1 | Lang Li, PhD | Associate Professor, Department of Medical & Molecular Genetics, IU School of Medicine | Drug interaction and drug safety/repositioning – a translational biomedical informatics approach |
| NOV 8 | Brittney-Shea Herbert, PhD | Associate Professor, Department of Medical & Molecular Genetics, IU School of Medicine | Targeting Telomerase in Cancer |
| MON NOV 14 2:00pm |
Jasmine Talameh, PhD | Eshelman School of Pharmacy, University of North Carolina | Pharmacogenetics and Heart Failure Patient Survival |
| NOV 15 | Richard Kim, MD, FRCPC | Division Chair, Clinical Pharmacology, University of Western Ontario | Drug Transporters and metabolizing enzymes: Pharmacogenomics & Clinical Relevance |
| NOV 22 | Thanksgiving Week - No Seminar | ||
| NOV 29 | David Jones, PhD | Assistant Research Professor, Division of Clinical Pharmacology, IU School of Medicine | Effect of Chronic Tamoxifen Treatment on CYP Activity |
| DEC 12 | Wanqing Liu, Ph.D | Assistant Professor Department of Medicinal Chemistry & Molecular Pharmacology College of Pharmacy Purdue University | A systems approach to delineate the human hepatic fat accumulation |
| *DEC 13 | Mick Murray, PharmD, MPH | Professor, Department of Pharmacy Practice, Purdue University | Update on Comparative Effectiveness Research and Policy |
| DEC 20 | Walter Kraft, M.D. | Associate Professor, Department of Pharmacology & Experimental Therapeutics, Jefferson Medical College | Novel Treatments for the Neonatal Abstinence Syndrome |
| DEC 27 | Holiday - No seminar | ||
| JAN 3 | Holiday - No seminar | ||
| JAN 10 | Eric Sherer, PhD | Division of Clinical Pharmacology Fellow, IU School of Medicine | A computer-based decision tool for colonoscopy preparation |
| JAN 17 | Philip Johnson, PhD | Assistant Research Professor, Department of Psychiatry, IU School of Medicine | The Role of the Hypothalamic Orexin System in Menopause-associated "Hot Flashes" and Mood Disruption |
| JAN 24 | Cancelled | ||
| *JAN 31 | Wanqing Liu, Ph.D | Assistant Professor, Department of Medicinal Chemistry & Molecular Pharmacology, College of Pharmacy Purdue University | GWAS of Cancer Risk: Do We Have the Right Phenotype? |
| JAN 31 | Jessie Lu | Division of Clinical Pharmacology Graduate Student, IU School of Medicine | Cancelled |
| FEB 7 | Veronique Michaud, PhD | Division of Clinical Pharmacology Fellow, IU School of Medicine | Cancelled |
| *FEB 14 | David Ingram Jr., MD | Associate Professor, Department of Pediatrics, IU School of Medicine | Understanding the Pathogenesis of Vascular Disease In Neurofibromatosis Type I Patients: Insights from Mouse Models and Human Clinical Trials |
| FEB 21 | Karen White, CLP | Research Development & Commercialization Facilitator | Research Commercialization Support for Faculty at IUPUI |
| FEB 28 | Todd Skaar, Ph.D. | Associate Research Professor of Medicine, Division of Clinical Pharmacology, IU School of Medicine | Pharmacogenomics of CYP2D6: basic regulatory mechanisms to clinical guidelines. |
| FEB 29 2-3PM |
Anita Grover | University of California, San Francisco | The Clinically Relevant Half Life in Pharmacokinetics and Pharmacodynamics |
| MAR 6 | Jason Robarge | Division of Clinical Pharmacology, IU School of Medicine | Losing estrogen is such a pain! Towards an experimental model of aromatase inhibitor-induced musculoskeletal syndrome |
| MAR 13 | ASCPT - No seminar | ||
| *MAR 20 | Troy Quigg, DO | Division of Clinical Pharmacology Fellow, IU School of Medicine | Tryptophan metabolism: a new direction for supportive care in HSCT |
| MAR 27 | Milan Radovich, Ph.D. | Assistant Research Professor |
Next generation sequencing in cancer research and personalized medicine |
| APR 3 | Yasmeen Rahimi | Department of Biochemistry, IU School of Medicine | Assistant Professor of Medicine, Brigham & Women’s Hospital |
| APR 10 | Cancelled | ||
| APR 17 | Richard Jones, PhD | University of Chicago | Integrating systems-level protein measurements into a pipeline for personalized medicine |
| APR 24 | Claire Xu | Division of Clinical Pharmacology, IU School of Medicine | Mechanism of altered efavirenz metabolism by the CYP2B6*6 allele in vitro |
| APR 30 | Emile Mohler III, MD | Professor of Medicine, University of Pennsylvania | The Vascular Health Profile: Cytomics as Personalized Medicine |
| *MAY 1 | Bryan Schneider | Assistant Professor, Division of Hematology/Oncology | Cancelled |
| MAY 8 | Jim Tisdale, PharmD, BCPS, FCCP | Department of Pharmacy Practice, Purdue University | Effectiveness of a clinical decision support system incorporating a validated QT interval prolongation risk score for reducing the risk of QT prolongation in hospitalized patients |
| May 15 | Claire Li | Division of Clinical Pharmacology Graduate Student, IU School of Medicine | Cancelled |
| MAY 22 | Eric Benson, MD | Division of Clinical Pharmacology Fellow, IU School of Medicine | |
| June 5 | Kelan Tantisira, MD, MPH | Assistant Professor of Medicine, Brigham & Women’s Hospital | Asthma Pharmacogenetics - Progress toward Prediction |
